SARS-CoV-2, a single-stranded RNA coronavirus, causes an illness known as coronavirus
disease 2019 (COVID-19). Long-term complications are an increasing issue in patients who …

Background Nearly 40% of patients who experience smell loss during SARS-CoV-2
infection may develop qualitative olfactory dysfunction, most commonly parosmia. Our …

Background: Sudden smell loss is a specific early symptom of COVID-19, which, prior to the
emergence of Omicron, had estimated prevalence of~ 40% to 75%. Chemosensory …

Background Olfactory dysfunction (OD)—including anosmia and hyposmia—is a common
symptom of COVID-19. Previous studies have identified olfactory training (OT) as an …

Background: Although smell and taste disorders are highly prevalent symptoms of COVID-
19 infection, the predictive factors leading to long-lasting chemosensory dysfunction are still …

Background Previous studies provided the first evidence that the importance of olfaction
decreases with the duration of olfactory dysfunction (OD). Objective To evaluate differences …

Objectives The present study aimed to assess the 4‐and 8‐week recovery rate of anosmia
and determine the factors associated with recovery in COVID‐19 patients. Method This …

Introduction: No studies have reported data on 2-year prevalence and recovery rates of self-
reported COVID-19-related quantitative and qualitative olfactory and gustatory dysfunction …

Parosmia is a well-documented consequence of smell loss associated with Covid 19. Those
who experience this qualitative olfactory disorder during recovery find that the odour of …

Abstract Purpose of Review The purpose of this review was to summarize the current
knowledge on parosmia and phantosmia and introduce support and treatment algorithms for …